Sublocade Long-Term Outcomes

This observational study is looking at the long-term outcomes in individuals adults with Opioid Use Disorder.

Type of Study: Observational

Who can participate: Individuals with a diagnosis of Opioid Use Disorder/Opioid Dependence who have initiated treatment with SUBLOCADE within the past 3 months

How long is participation: Up to 4 years*

Is there compensation? Yes

VENTURA-1 Study (Major Depressive Disorder)

The purpose of this study is to evaluate the efficacy and safety of a once daily oral study medication in adults and elderly people with depression who continue to have depressive symptoms despite taking antidepressant medication.

• Type of Study: Interventional (Investigational Drug)
• Who can participate: Individuals with a diagnosis of Major Depressive Disorder, ages 18-74
• How long is participation: 12 weeks; 10 study visits, 6 in-person and 4 over the phone.
• Is there compensation? Yes

Major Depressive Disorder Study

This clinical research study is looking to learn more about how well an investigational study drug works in addition to standard treatment for people with Major Depressive Disorder (MDD).

• Type of study: Interventional (Investigational Drug)
• Who can participate: Individuals with a diagnosis of Major Depressive Disorder, ages 18- 65
• How long is participation: 9 weeks; 8 study visits
• Is there compensation? Yes

RECOVER (Bipolar Depression)

The RECOVER Study is a research study that will provide new information about how helpful VNS Therapy (Vagal Nerve Stimulation) is for patients with bipolar depression that has been difficult to treat.

• Type of study: Interventional (Investigational Device)
• Who can participate: Individuals with Bipolar Depression, considered Treatment Resistant (have tried at least four antidepressant treatments and not found helpful), ages 18 or older
• How long is participation: 1-4 years*
• Is there compensation? Yes

KU Autism Research Study

The KU Center on Autism Research and Training (KCART) is recruiting for a study that examines the effects of a medication named Pimavanserin on behavioral rigidity and restrictive repetitive behavior within individuals with Autism Spectrum Disorder, or ASD.

• Type of study: Interventional (Investigational Drug)
• Who can participate: Individuals with a diagnosis of Autism Spectrum Disorder, ages 16-40; must have a caregiver who is willing to help complete study activities
• How long is participation:10 weeks, 6 study visits
• Is there compensation? Yes

FXS Trials (Fragile X Syndrome)

Two studies are recruiting males aged 9 to 45 to participate in potential registration trials for new treatment for FXS, to be followed by a 2-year open-label extension study in which all subjects will receive active treatment

• Type of study: Interventional (Investigational Drug)
• Who can participate: Adolescent males, ages 9-17, weighing ≥ to 55lbs and ≤ to 97th percentile of BMI for age; adult males, ages 18-45, with BMI between 18-36 kg/m2
• How long is participation: 13 weeks
• Is there compensation? Yes